Associations between prognostic index scores and plasma neurofilament light in Huntington's disease
Open Access
- 4 March 2022
- journal article
- research article
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 97, 25-28
Abstract
No abstract availableKeywords
Funding Information
- University of California, San Diego
- National Institutes of Health (NS111655)
- National Institutes of Health (P50 AG005131)
This publication has 11 references indexed in Scilit:
- Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington’s diseaseScience Translational Medicine, 2020
- Clinical Outcomes and Selection Criteria for Prodromal Huntington's Disease TrialsMovement Disorders, 2020
- Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysisThe Lancet Neurology, 2020
- Huntington's Disease Progression: A Population Modeling Approach to Characterization Using Clinical Rating ScalesThe Journal of Clinical Pharmacology, 2020
- Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysisThe Lancet Neurology, 2017
- Cognitive and behavioral changes in Huntington disease before diagnosis2017
- Validation of a prognostic index for Huntington's diseaseMovement Disorders, 2016
- CAG‐repeat length and the age of onset in Huntington disease (HD): A review and validation study of statistical approachesAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2010
- Estimation of the Youden Index and its Associated Cutoff PointBiometrical Journal, 2005
- Unified Huntington's disease rating scale: Reliability and consistencyMovement Disorders, 1996